Skip to Content

DepoDur FDA Approval History

FDA Approved: Yes (Discontinued) (First approved May 18, 2004)
Brand name: DepoDur
Generic name: morphine sulfate
Dosage form: extended-release liposome Injection
Company: SkyePharma PLC and Endo Pharmaceuticals
Treatment for: Pain

Marketing Status: Discontinued

DepoDur (morphine sulfate extended-release liposome injection) is an opiate for the treatment of pain following major surgery.

Development Timeline for DepoDur

DateArticle
May 18, 2004Approval DepoDur SkyePharma PLC and Endo Pharmaceuticals - Treatment for Post-Surgical Pain Relief

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.